Valuation: Iqvia Holdings Inc.

Capitalization 28.31B 23.86B 21.76B 20.77B 38.56B 2,564B 40.07B 253B 100B 1,238B 106B 104B 4,328B P/E ratio 2025
28.8x
P/E ratio 2026 * 19.9x
Enterprise value 41.66B 35.1B 32.02B 30.57B 56.74B 3,773B 58.95B 372B 148B 1,822B 156B 153B 6,368B EV / Sales 2025
3.2x
EV / Sales 2026 * 2.41x
Free-Float
67.55%
Yield 2025 *
-
Yield 2026 * -
1 day-1.13%
1 week-10.96%
Current month-27.46%
1 month-30.89%
3 months-25.32%
6 months-12.24%
Current year-25.94%
1 week 156.66
Extreme 156.665
194.83
1 month 156.66
Extreme 156.665
244.16
Current year 156.66
Extreme 156.665
247.04
1 year 134.64
Extreme 134.645
247.04
3 years 134.64
Extreme 134.645
261.73
5 years 134.64
Extreme 134.645
285.61
10 years 60.23
Extreme 60.23
285.61
Manager TitleAgeSince
Chief Executive Officer 65 03/10/2016
Director of Finance/CFO 65 01/08/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 05/02/2015
Director/Board Member 60 01/01/2008
Chairman 65 03/10/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.13%-10.96%-14.85%-28.08% 28.31B
+4.62%+0.73%-12.88%-4.40% 47.61B
-0.10%-2.22%+53.47%+41.20% 38.3B
-0.21%+8.18%+39.13%+61.33% 36.11B
-1.05%-1.21%+133.08%+277.09% 18.62B
+7.58%+14.65%+33,042.25%+4,133.79% 15.44B
+2.25%-3.74%+29.62%-3.02% 13.72B
-0.82%-2.62%+51.81%+89.94% 13.28B
-1.44%-6.82%+165.57%+103.18% 13.06B
+2.88%-21.03%+25.01%+87.04% 12.15B
Average +1.26%-2.97%+3,351.22%+475.81% 23.66B
Weighted average by Cap. +1.31%-1.95%+2,191.96%+318.38%

Financials

2025 2026 *
Net sales 16.18B 13.64B 12.44B 11.87B 22.04B 1,466B 22.9B 145B 57.43B 708B 60.69B 59.44B 2,474B 17.22B 14.51B 13.23B 12.63B 23.45B 1,560B 24.37B 154B 61.1B 753B 64.57B 63.25B 2,632B
Net income 1.23B 1.04B 946M 903M 1.68B 111B 1.74B 11B 4.37B 53.81B 4.61B 4.52B 188B 1.44B 1.22B 1.11B 1.06B 1.97B 131B 2.04B 12.9B 5.12B 63.13B 5.41B 5.3B 221B
Net Debt 13.35B 11.25B 10.26B 9.79B 18.18B 1,209B 18.89B 119B 47.36B 584B 50.05B 49.02B 2,040B 13.21B 11.13B 10.15B 9.69B 17.99B 1,196B 18.69B 118B 46.87B 578B 49.53B 48.51B 2,019B
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).
Employees
93,000
Date Price Change Volume
13/02/26 166.94 $ -1.13% 4,265,627
12/02/26 168.85 $ -4.70% 7,055,519
11/02/26 177.18 $ -2.89% 4,558,876
10/02/26 182.45 $ -5.30% 3,647,315
09/02/26 192.67 $ +2.76% 2,045,149
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
166.94USD
Average target price
246.10USD
Spread / Average Target
+47.42%

Quarterly revenue - Rate of surprise